Y0001485

Rivastigmine for system suitability

European Pharmacopoeia (EP) Reference Standard

Manufacturer: Sigma Aldrich

CAS Number: 129101-54-8

Synonym(S): Rivastigmine tartrate, ENA-713, Ethylmethyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, N-Ethyl-N-methyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester tartrate, S-Rivastigmine tartrate

Select a Size

Pack Size SKU Availability Price
1.01 MG Y0001485-1.01-MG In Stock ₹ 15,966.88

Y0001485 - 1.01 MG

₹ 15,966.88

In Stock

Quantity

1

Base Price: ₹ 15,966.88

GST (18%): ₹ 2,874.038

Total Price: ₹ 18,840.918

grade

pharmaceutical primary standard

API family

rivastigmine

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

InChI

1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m00/s1

InChI key

GWHQHAUAXRMMOT-RWALOXMOSA-N

Description

  • General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
  • Application: Rivastigmine for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
  • Biochem/physiol Actions: Rivastigmine is an orally available, brain penetrant, reversible cholinesterase inhibitor that enhances cognitive function in patients with Alzheimer′s and Parkinson′s diseases. Rivastigmine inhibits both butyrylcholinesterase and acetylcholinesterase.
  • Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
  • Other Notes: Sales restrictions may apply.

SAFETY INFORMATION

Pictograms

GHS06,GHS09

Signal Word

Danger

Hazard Statements

H300,H411

Precautionary Statements

P264 - P270 - P273 - P301 + P310 - P391 - P405

Hazard Classifications

Acute Tox. 2 Oral - Aquatic Chronic 2

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Compare Similar Items

Show Difference

Img

Sigma Aldrich

Y0001485

European Pharmacopoeia (EP) Referen...


grade:
pharmaceutical primary standard

API family:
rivastigmine

manufacturer/tradename:
EDQM

application(s):
pharmaceutical (small molecule)

format:
neat

storage temp.:
2-8°C

InChI:
1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m00/s1

InChI key:
GWHQHAUAXRMMOT-RWALOXMOSA-N

Img

Sigma Aldrich

Y0001486

European Pharmacopoeia (EP) Referen...


grade:
pharmaceutical primary standard

API family:
pyridostigmine

manufacturer/tradename:
EDQM

application(s):
pharmaceutical (small molecule)

format:
neat

storage temp.:
2-8°C

InChI:
__

InChI key:
__

Img

Sigma Aldrich

Y0001487

European Pharmacopoeia (EP) Referen...


grade:
pharmaceutical primary standard

API family:
butylated methacrylate copolymer

manufacturer/tradename:
EDQM

application(s):
__

format:
__

storage temp.:
__

InChI:
__

InChI key:
__

Img

Sigma Aldrich

Y0001488

European Pharmacopoeia (EP) Referen...


grade:
pharmaceutical primary standard

API family:
__

manufacturer/tradename:
EDQM

application(s):
__

format:
__

storage temp.:
__

InChI:
__

InChI key:
__